A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting

Diabetes Research and Clinical Practice

Volumn 75, Issue 2, 2007, Pages 141-147

  Cesur, Mustafa ^a   Corapcioglu, Demet ^b   Gursoy, Alptekin ^b   Gonen, Sait ^c   Ozduman, Mine ^b   Emral, Rifat ^b   Uysal, Ali Riza ^b   Tonyukuk, Vedia ^b   Yilmaz, Arif Ender ^b   Bayram, Fahri ^d   Kamel, Nuri ^b  

^a GÜVEN HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c SELCUK UNIVERSITY   (Turkey)

^d ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Fasting; Glimepiride; Glucose parameters; Insulin glargine; Lipid parameters; Ramadan; Repaglanide; Type 2 diabetes

Indexed keywords

CHOLESTEROL; FRUCTOSAMINE; GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN GLARGINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT; REPAGLINIDE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; LIPID BLOOD LEVEL; MALE; MOSLEM; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL SIGNIFICANCE;

ADULT; BODY MASS INDEX; CARBAMATES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLAM; MALE; MIDDLE AGED; PATIENT SELECTION; PIPERIDINES; SULFONYLUREA COMPOUNDS; TURKEY;

EID: 33845385392     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.05.012     Document Type: Article

References (25)

1. Al-Arouj M., Bouguerra R., Buse J., Hafez S., Hassanein M., Ibrahim M.A., et al. Recommendations for management of diabetes during Ramadan. Diabetes Care 28 (2005) 2305-2311
2. The Glimepiride in Ramadan (GLIRA) Study Group. The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan. Diabetes Care 28 (2005) 421-422
3. Salti I., et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27 (2004) 2306-2311
4. Larijani B., Zahedi F., Sanjari M., Amini M.R., Jalili R.B., Adibii H., et al. The effect of Ramadan fasting on fasting serum glucose in healthy adults. Med. J. Malaysia 58 (2003) 678-680
5. Uysal A., Erdogan M.F., Sahin G., Kamel N., and Erdogan G. Clinical and metabolic effects of fasting in 41 type 2 patients during Ramadan. Diabetes Care 21 (1998) 2033-2034
6. Sari R., Balci M.K., Akbas S.H., and Avci B. The effects of diet, sulfonylurea, and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr. Res. 30 (2004) 169-177
7. Yarahmadi Sh., Larijani B., Bastanhagh M.H., Pajouhi M., Baradar Jalili R., Zahedi F., et al. Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. J. Coll. Physicians Surg. Pak. 13 (2003) 329-332
8. Laajam M.A. Ramadan fasting and non-insulin-dependent diabetes: effect on metabolic control. East. Afr. Med. J. 67 (1990) 732-736
9. Mafauzy M., Mohammed W.B., Anum M.Y., Zulkifli A., and Ruhani A.H. A study of the fasting diabetic patients during the month of Ramadan. Med. J. Malaysia 45 (1990) 14-17
10. Khatib F.A., and Shafagoj Y.A. Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes mellitus patients in relation to food intake. Saudi Med. J. 25 (2004) 1858-1863
11. Gustaviani R., Soewondo P., Semiardji G., and Sudoyo A.W. The influence of calorie restriction during the Ramadan fast on serum fructosamine and the formation of beta hydroxybutirate in type 2 diabetes mellitus patients. Acta Med. Indones. 36 (2004) 136-141
12. Katibi I.A., Akande A.A., Bojuwoye B.J., and Okesina A.B. Blood sugar control among fasting Muslims with type 2 diabetes mellitus in Ilorin. Niger J. Med. 10 (2001) 132-134
13. Salman H., Abdallah M.A., and Howasi M. Ramadan fasting in diabetic children in Riyadh. Diabet. Med. 9 (1992) 583-584
14. Friedrich I., and Levy Y. Diabetic ketoacidosis during the Ramadan fast. Harefuah 138 (2000) 19-21
15. Belkhadir J., el Ghomari H.H., Klocker N., Mikou A., Nasciri M., Sabri M., et al. Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide. BMJ 307 (1993) 292-295
16. Mafauzy M. Repaglinide versus glibenclamide treatment of type 2 diabetes during Ramadan fasting. Diabetes Res. Clin. Pract. 58 (2002) 45-53
17. Kadiri A., Al-Nakhi A., El-Ghazali S., Jabbar A., Al Arouj M., Akram J., et al. Treatment of type 1 diabetes with insulin lispro during Ramadan. Diabetes Metab. 27 (2001) 482-486
18. Akram J., and De Verga V. Insulin lispro Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan Study Group. Diabet. Med. 16 (1999) 867-874
19. Mattoo V., et al. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Diabetes Res. Clin. Pract. 59 (2003) 137-143
20. Goldstein D.E., Little R.R., Lorenz R.A., Malone J.I., Nathan D., and Peterson C.M. Tests of glycemia in diabetes. Diabetes Care 18 (1995) 896-909
21. Afrasiabi A., Hassanzadeh S., Sattarivand R., Nouri M., and Mahbood S. Effects of low fat and low calorie diet on plasma lipid levels in the fasting month of Ramadan. Saudi Med. J. 24 (2003) 184-188
22. Aldouni A., Ghalim N., Benslimane A., Lecerf J.M., and Saile R. Fasting during Ramadan induces a marked increase in high-density-lipoprotein cholesterol and decrease in low-density-lipoprotein cholesterol. Ann. Nutr. Metab. 41 (1997) 242-249
23. Maislos M., Khamaysi N., Assali A., Abou-Rabiah Y., Zvili I., Shany S., et al. increase in plasma high-density-lipoprotein cholesterol after prolonged fasting during Ramadan. Am. J. Clin. Nutr. 57 (1993) 640-642
24. Lam S. Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus. Heart Dis. 5 (2003) 231-240
25. Mucha G.T., Merkel S., Thomas W., and Bantle J.P. Fasting and insulin glargine in individuals with type 1 diabetes. Diabetes Care 27 (2004) 1209-1210